Hanbio

Hanbio is a prominent biotechnology company headquartered in Shanghai, specializing in the development and manufacturing of viral vector systems for gene and cell therapy. The company offers a broad suite of services, including the production of high-titer lentivirus, adenovirus, and adeno-associated virus (AAV) vectors, as well as CRISPR/Cas9 gene-editing tools. As a dual-function CRO and CDMO, Hanbio supports global biopharmaceutical partners from early-stage research through clinical-grade manufacturing. Their technical expertise also encompasses mRNA synthesis and the development of stable cell lines for complex therapeutic applications. With state-of-the-art GMP facilities, Hanbio is a key player in the rapidly expanding genetic medicine sector in Asia and beyond.